Clinical Trials Browser

Phase 1/2 × Sorafenib × Other solid neoplasm × Clear all

NCT01226056 2010-10-21

Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets

Phase 1/2 Suspended

Other solid neoplasm

Advanced Solid Tumors